Enhanced TACE therapy for HCC_InnoBM Pharmaceutics

PIPELINE LAYOUT

Discovery

IND-Enabling Studies

IND

Phase1

Phase2-3

Immuno-agonist long-term
sustained-release
preparation
BM201
Add-on treatment for radiotherapy / ablation therapy against solid tumors

Add-on treatment for radiotherapy / ablation therapy against solid tumors

FOR bladder tumors

FOR solid tumors

Enhanced TACE therapy for HCC

Add-on treatment for radiotherapy / ablation therapy against solid tumors

BM201Immuno-agonist long-term
sustained-release
preparation

GLP

FOR bladder tumors

BM101Immuno-agonist / ICD
chemotherapeutic drug
complex formulation

Pre- IND

FOR solid tumors

BM501Oncolytic biomineralized bacteri

CMC

Enhanced TACE therapy for HCC

BM601TME-modulating microspheres

CMC

Unit 104, Building A4, No.218 Xinghu Street,

Suzhou Industrial Park, Jiangsu Province, CHINA

Tel：0512-69386599

技术管线